Real-world clinical benefit among patients with lower-risk myelodysplastic syndromes treated with luspatercept
07:30am - 03:35pm EST - April 5, 2024
07:30am - 03:35pm EST - April 5, 2024
Abstract: JNCCN23-0620 https://jnccn.org/view/journal...
Author(s):
- Kashyap Patel, MD, Minnesota Oncology
- Derek Tang, PhD, MS, BSPharm, Health Outcomes Research Leader, Bristol-Myers Squibb
Tags: Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| NCCN 2024 Patel poster_RW Outcomes with 1L Lusp_HR.pdf | Download Handout |
| AC24P22 - Real-world clinical benefit among patients with lower-risk myelodysplastic syndromes treated with luspatercept | Download MP3 |